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To extend our observation that recombinant I'interferon 
(r-IFN-I') indu ces the synthesis and expression of HLA-
DR antigen w e have inves tiga ted 2 m ajor areas including 
the m odulation of r-IFN-I'-induced HLA-DR expression 
and the possible immunologic conseguences of keratin o-
cyte HLA-DR expression in vitro. The indu ction of ke-
ratinocyte HLA-DR expression w as g reater for continuous 
compared with pulse dosage (0.5-24 h) of r-IFN-I' and was 
m arkedly decreased after trypsiniza tion of attached mono-
layers into single cell suspensions. The r-IFN-I' caused in-
duction of HLA-DR and this w as no t influenced by either 
pretreatment with irradiation , PGE2, o r indomethacin . Both 
HLA-DR + and HLA-DR - cultured keratinocytes indu ced 
RNA synthesis and l' interferon production by allogeneic 
T he maintenance of cutaneous ho meostasis probabl y depends on complex cellular in tera ctions between ke-ratinocy tes (KCs), Langerh ans cells (LC s) , T lym-phocytes , and o ther lymphoid cell s (B lymphocytes, monocytes, natural killer cells, etc. ). 
Keratinocytes produce soluble fac tors which ca n stimulate lym-
phocyte proliferation [epidermal cell-deri ved thymocy te activat-
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Abbreviations: 
BSA: bovine serum albumin 
Con A: concanavalin A 
D MEM : Dulbecco's modified Eagle's medium 
ELR: mixed epide rmal cell-lym phocyte reaction 
ETAF: epidermal cell-deri ved thymocyte-activating facto r 
FA C S: flu oresccnce-activa ted cell sorter 
FCS: fe tal ca lf serum 
FITC: fluorescein iso thiocyanate 
HLA-DR: class II histocompatibili ty antigen 
IFN : interferon 
IL: interleukin 
KC: kcratinocyte 
KLIF: keratinocyte-deri ved lymphocyte inhibito ry fac to r 
LC: Langerhans cell 
MLR: mixed lymphocyte reaction 
pBML: periphcral blood mononuclear leukocy tes 
PGE2: pros taglandin E2 
r-IFN-y: reco mbinant ga mma interferon 
peripheral blood m ononuclea r leukocytes (PBMLs) indi-
ca ting mononuclea r cell acti va tion . H owever , this acti va-
tion was no t follow ed by signifi cant mitogenesis and only 
slightl y in creased levels of [3H] thymidine incorporation 
(maxi mal = 5800 cpm) by the PBMLs was observed . C ul-
tured keratinocytes apparently inhibit bo th lectin-driven 
and mixed-lymphocyte reactions by producing a soluble 
mediato r which is not dialyzable, or inhibited by pretrea t-
ment with indomethacin or anti-a, -{3, -1' interferon an-
tibodies. These results suggest that Iymphocyte-keratino-
cyte reactions in vitro are complex and m ay be m ediatl;d 
by a variety of cytokines, lymphokines, and pros taglandins. 
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ing factor (ETAF)] as well as diffe rentiation (th ymopoietin) [1 -3]. 
By contras t, human skin homogenates inhibit lymphocyte cy-
to toxicity and mitogen-induced lymphocyte transformation [4]. 
D efin ed KC-derived produ cts which can inhibit lymphocyte pro-
li fe ration include pros taglandin E2 (PGE2), and interferon (IFN) 
[5- 7]. M oreover, lyn'lphocytes, by producing y interfe ron (IFN-
y), induce the synthesis and expression of HLA-DR by KCs, 
inhibit KC proliferation, and appear to influence KC differentia-
tion in vitro [8-1 0]. Thus, KCs and mononuclea r leukocytes may 
reciprocall y influence each o ther 's proliferation and differentiation 
via soluble fac tors such as cytokines, lymphokines, and prosta-
glandins. 
Although we have demonstrated that KCs synthesize and ex-
press the light and hea vy chains of the HLA-DR molecule after 
recombinant y interferon (r-IFN-y) exposure, the biologic sig-
nifi cance of this HLA-DR express ion by KCs is unknown [11]. 
T he expression o f HLA-DR on bone marrow-derived cells such 
as m3crophages, T lymphocy tes , and LCs is important in con-
ferrin g antigen presentation capabilities, eliciting mixed lympho-
cyte reacti ons (MLRs) and allograft rejection [1 2]. O ther inves-
tigators have studied the interaction between lymphocytes and 
o ther non-bone marro w-deri ved cells (e.g., endothelium, fib ro-
blas ts) both w ith and without IFN-y exposure [1 3-1 6]. In this 
report we document our fin dings using KCs as the stimulator 
cell befo re and after r-IFN-y exposure. 
T his paper covers 2 maj or areas. T he first part includes studies 
of the modulation of IFN-y induction of KC H LA-D R expres-
sion. T he second part describes studies of the in teraction between 
restin g and activated , allogeneic, peripheral blood m ononu clea r 
leukocytes (PBMLs) using HLA-DR - and HLA-D R + cultured 
KCs. 
MATERI ALS AN D METH ODS 
Preparation of Keratinocy te Cultures Single cell suspen-
sions of normal skin ob tained at the time of face-lift surgery were 
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prepared accord ing to the method of Liu and Karasek 11 7]. Small , 
round, viab le cells were seeded on 3.5-cm collagen-coated Petri 
dishes (Lux, Flow Laboratories, Inc.) o r 96- well fl at-bottomed 
microtiter pl ates (Linbro , Flow Laboratories , M cLean , Virginia) 
in Dulbecco's modifi ed Eagle's medium (DMEM) containing 1.4 
mM ca lcium, supplem ented w ith 10% hea t-in ac tivated fetal ca lf 
serum (FCS), 50 ,ug/ml of gentamicin , and 2 m M I.-glutamine 
(co mplete medium). Seed ing ce ll densities varied and are indi ca ted 
for each ex periment. 
Vi ability as determined by trypan blue exclusio n iml1lediately 
fo llowing trypsiniza ti on was 90% o r better. The cells were main-
tained in a humidifi ed incubator w ith 5% CO2/95% air at 37°C. 
In certain experiments, indometha cin (S ig ma C hemi ca l Co ., St. 
Louis, Missouri) o r PGE2 (a gift of Dr. A. C. Alliso n, Syntex 
Corp. , Palo Alto , Ca li forn ia) was inclu ded in th e co mpl ete media 
at the time of th e initi al seedin g and in subsequent med ia changes . 
R-fFN-y was added 2-3 days after cell seedin g. All tim e points 
indi ca ted refer to th e tim e of ad diti o n of r-IFN-y as day O. De-
termination of cell number and viability utilizing a hemocyto-
meter and O lympus in verted mi croscope was performed as pre-
viously described [1 0J. 
Interferon and Antibodies Against Interferons Hum an r-
IFN-y, genero usly suppli ed by Dr. G . Burton (Genentech In c., 
South San Fran cisco, Califo rnia) , had a specifi c activity o f 3.0 X 
106 units/mg as determin ed by virus inhibition plaque assay . 
Anti-a, -{3, and -y interfero n antibodies were obtained fro m 
th e N atio nal Institutes of Hea lth . These reagents were sheep anti-
sera (catalog nos. G-026-502- 568,G-028-501-568; ant i-a, and anti-
{3, res pectivel y) and rabbit antise ra (catalog no. G-034-501-565; 
anti- y). Contro l antiseras (shee p and rabbit) were also utilized 
(ca talog nos. G-027-501 -568 , G-035-501-565) . 
Measurelnent of y Interferon y-Interferon was measured in 
culture supern ata nts by a sensiti ve an d specifi c radioimmunoassay 
(Centoco r, Inc., Malvern , Pennsylvani a) whi ch employs a dou-
ble-sandwich techniqu e using o ne radiolabeled and a second fi xed 
mo noclon al antibod y to biologica lly active human IFN-y. 
Keratinocyte HLA-DR Staining Keratinocy te HLA-DR 
staining in vo lved trypsiniza tion of cultured KC monolayers using 
0.3% trypsin plus 1% EDTA. Aliquots o f 106 viable cell s w ere 
indirectl y sta ined for 10 min on ice with 1 ,ug of monoclonal 
antibod y (anti-HLA-DR; L243; Becton D ickinso n M o noclonal 
Center, Mountain View, Ca lifo rni a) diluted in heat-inactivated 
FCS containing 0.1% sodium azi de. Nonspecifi c background 
sta ining was determ ined with control isotypes. The cells were 
then was hed and sta ined w ith 1 ,ug flu o rescein iso thi ocyanate 
(F ITC)-conjugated goa t anti mo use IgG (Becton-Di ckinson). The 
flu o rescence per cell was determined wi th a fluorescence-activated 
cell so rter (FACS 1fI; Becton-Dickinso n) , and a histog ram show-
in g th e number of cell s aga inst the intensity o f flu o rescence was 
100 
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recorded. All values presented have had nonspecifi c backg round 
and isotype control va lues subtracted. 
Determination of PGEz Levels The radi oimmunoassay for 
PGE2 was performed usin g rabbit antihuman PGE-bovinc serum 
albumin (PGE-BSA) serum (Milcs-Yeda , Ltd.) acco rdin g to the 
proced ure described in the Miles bulletin . [JHjProsta glandin E2 
(New England Nuclear; sp act 210 C i/ mmo l) was used as the 
tra cer. 
Preparation of Peripheral Blood Mononuclear Cells; Con-
ditions of the Mixed Lymphocyte Reaction and Lectin 
Stimulation Peripheral blood mo no nuclear leukocy tes, w hich 
were used as res ponder cell s, were o btained by centrifugation of 
defibrini zed venous blood ove r Fi coll-H ypaque density g radients . 
The in te rface cell s were co llected and washed with RPMl 1640 
(Gibco, G rand Island , New York) . 
Fo r control MU~s, all ogeneic stimulator PBMLs were irradi-
ated with 3000 rad from a Cs source and w ere co mbined w ith 
nonirradi ated res pond er PBML in RPMI medium co ntainin g 
10-15% reca lcifi ed human plas ma (3 gift of Dr. E. Eng leman) to 
fl at-bottom cd 96- well culture pl ates. After add iti on of PBML, 
so me of the 96- well plates w ere cen trifuged at 200 g for 1-2 min . 
After 6 days o f incubati on in 37°C humidifi ed air containin g 10% 
CO2, 10 ,ul o f 0.1 mC i/ ml lJH]th ymidine (sp act 6 C i/ mll1 oJ ; 
Schwartz / Mann , Cambrid ge, M assachusetts) were added per well 
and the cultures harvested 18 h later 9 n a PHD cell harvester 
(Ca mbrid ge Tech nology, Ca mbridge, Massachusetts). Fo r the 
uridin e inco rpo rati on studies, a final concentratio n of 5 ,uC i/ mJ 
[3H]uridinc (sp act 37.4 C i/ mmol ; N ew England Nuclea r, Bos-
to n, Massachusetts) was used durin g a 4- h pulse. Cell-associated 
radioactivity was measured by scintill ation cOllnting (Beckman 
Scinti ll at ion Counter , m odel LS 7000) and the res ults we re ex-
pressed as the mean o f triplica te cultures. 
The results presented in Figs 4 and 5 represent the mean of 6 
expe riments and includcd the combination o f 5-10 X 104 re-
sponder PEML, 5-10 X 104 irradiated allogeneic stimulator PBML, 
and various numbers of K C. Peripheral blood mononuclea r cell 
size was determined by th eir lig ht sca tter on th e FACS and b y 
visualiza tion in a hem ocy to m eter. For dialyzed media , cell-free 
supernatants from attached cultured KC cond itio ned fo r va rious 
tim e in tervals in RPMI media w ere o btained and dial yzed over-
ni ght at 4°C aga inst 50 vol of RPMl (di alysis tubing mo lecular 
weight cutoff3500, Spectrapor-Spectrum Medica l Industries Inc., 
Los An geles, Ca lifo rni a) and then sterilized by Millipo rc filtra-
ti on. For mitogen stimulation , S X 104 PEM L were incubated 
w ith concanava lin A (Con A, Pharmacia Fine C hemica ls) and 
pul sed overn ight with [3Hlth ymidine (1 ,uC i/wcl l) o n day 3. 
RESULTS 
Modulation of r-IFN-y Interferon Induced Keratinocyte 
HLA-DR Expression To extend our initial observations re-
ga rdin g r-IFN-y induction of HLA-DR expression by cul tured 
nor-IFN - ~ 
no r-IFN-ll 
plus r-IFN-l (lOO U / ml) 
20 plus r-IFN - l (300 U/ml) 
single cultured \l.eratinocyte 
'----.1.-..--2::'..4,----L----'~':..8- suspenGion after removol 
of r - IFN-¥ hours 
Figure 1. Viability and HLA-DH expression of trypsin ized KC. So lid lilies: Human KC cul tured for 3 days in the presence or absence of 
r-IFN-')' (300 units /ml) trypsinized oCf co llagen-coated Petri dishes and either stained with monoclonal antibody against HLA-DR immediately 
(t = 0) or maintained in RPMI med ium . Dashcd lilies: Epiderma l cells trypsinized from the skin . Immediatel y aCter trypsiniza tion and washing, 
the cells were either treated with r-IFN- ')' (300 units/ ml) or untrea ted (controls). T he percent viabi lity is represented by Op CII (plus r-IFN- ')') or 
closed (no r- IFN-')') circles. HLA-DR ex pression on cultured KC trypsinized after r-IFN-')' treatment (3 days) (rriangles). 
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KC we ha ve ex posed the KC to va ri ous conditio ns includ in g : (1) 
trypsini za tion o f HLA-DH. ex pressin g KC; (2) bri ef pulses rather 
th an continu o us expos ure to r-IFN-y; and (3) p retrea tment of the 
KC w ith irradiation, PGE2, indo m eth acin . 
ViabililY alld HL A-D R Expressioll oj Trypsillized r-IFN-y- Trealed 
Keralill ocyles: An ini t ial co mpariso n was m ade between the v i-
ability of try psini zed fresh ep ide rm al cell s an d trypsini zed cultured 
K C when bo th are m aintained at 37°C in H.PMI medium , both 
w ith and w ith out r- IFN-y (300 units/ml). Fi g I revea ls that the 
v iability o f trypsinized cultured KC is decreased co mpared w ith 
tryps ini zed fresh ep ide rmal cell s. The decline in v iability is m o re 
m ark ed afte r r- IFN-y exposure fo r bo th cu ltured KC and fres h 
epiderm al ce ll s co mpared with untrea ted controls. The rapid de-
cline in HLA-DH. express ion o f the trypsini zed cultured KC (Fig 
1, triang les) parallel s the decreased viability orthe r-IFN-y-trea ted 
cultured K C. 
COlllpariso ll oJPlIlsillg vs ComillllOlls Exposllre to 1'-1 FN-y 0 11 Clllrllred 
KC HLA-DR Expressioll: The deg ree of indu ction and disa p-
pearance o f K C HLA-DR express ion after a brief ex pos ure of 
0.5,4, and 24 h to r- IFN-y (500 units/m l) is different th an wi th 
continuous expos ure to r- IFN-y (Fig 2). Less indu cti o n of HLA-
DR expression occurs after pu lsin g w ith r- ll=N-y co mpared w ith 
continu o us expos ure on days 1-6 (no t shown). A lso, by day 6, 
no signifi can t HLA-OR expression was detectable on the r- IFN-
y pul sed eultured KC. Cell s previosu ly pulsed wi th r- IFN-y dis-
played decreased cell den sity and in creased responsiveness for 
induction of HLA-DR compared with previously untrea ted con-
tro ls on da ys 6, 8, and 10. 
Influence oj Irradiatioll , PCE2, alld Illdolll ell,acill PrelrcallllclIl oj C III-
lIaed KC on HL A -DR Expression by r-IFN-y: The modul ation 
of th e induction and di sappearan ce of K C HLA-OH ex pression 
by pretrea tment w ith irradiatio n (2000 rads), PGE2 (0.1 fLg/ m l) , 
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Figure 2. Compa rison of pulsing vs continuous exposure to r-IFN-y on 
cultured KC HLA-DR expression. Kcratinocyte cultures were pulse treated 
with r-IFN-y (500 units/ ml), exposed continuously to r-IFN-y (500 units/ml 
and 50 units/ml), or not trea ted . Six da ys later, the previously pulsed 
cultures as we ll as controls were again trea ted with a col/lil/llol/ ; exposure 
to r-IFN-y (50 units/ml). 0 = 30-min pulse, 0 = 4-h pulse, • = 24-
h pulse, 0 = 500 units/ml r-IFN-y continuously, 0 = 50 units/ ml 
continuously from day 0, 0 = 50 units/ ml continuousl y from da y 6. 
HU MAN KERATINOCYTE-LYMPHOCYTE REA CTIONS 13 
o r ind o m cth acin ( I fLg/ ml) fo ll owed by continu ous ex posure to 
r-IFN-y (300 units / ml) for 3 days wi th subsequ ent thoro ugh 
washing is shown in Fi g 3. Neither the induction of HLA-DR 
no r th e disappearancc of HLA- OR cxpressio n was significantl y 
influcn ced b y any of th ese pretrcatment m odalities. T he rate of 
disa ppcarance of HLA-DR cx pressio n after co ntinuous cx po ure 
and then rem ova l of r-IFN-y is similar to our previous repon 
[1 81. Utilizing murine m acropha ges, it has been repo rted th at 
PGE2 (0 .1 fLg/ ml ; 3 x 10 - 6 M) modu lates bo th induction and 
disa ppearance o f ·la-like anti gen expression after IFN-y exposure 
[1 9]. 
Resting and Stimulated Allogeneic PBML Interactions with 
HLA- DR Expressing Cultured Keratinocytes To deter-
mine til e poss ible immuno logic co nsequences o f KC HLA-DR 
expression , we have exa mined a va ri ety of conditions in w hich 
HLA-OR exp ressin g KC are co mbined w ith all ogeneic PBML. 
Lack oj f HJ T IIJ,,"idil1e Ill corp a/'a lioll by Allogelleic PBML e llllllred 
lIIilil Trypsillized ill~~ /e Cell Slispellsiolls of H LA-DR + C IIIII/red 
K C: In the epider m al cc ll ly mph ocy te reaction (E LR) usin g epi-
derm al cells (5 x 104 ) whi ch had been trypsini zed from skin 
immediately befo re use plus allogeneic res ponder PBML (5 X 
104 cell s) , we consi stentl y observcd a stimulation index of30-40, 
confirming our ea rlier observatio ns [201. H owever, des pite a wide 
ran ge in conccntration of H LA-DH + cultured KC (103-105 cells) 
trypsini zed to g ive sing le ce ll suspensio ns, no stimulation of al-
logeneic PBML was measurabl e by 13H]thymidine uptake eith er 
on da y 4 o r day 7 afte r coin cubatio n. Also, n o stimulation of 
PBML occurred w hen wc co mbined 5 X 104 trypsinized K Cs 
with 25-75 X 103 PBML. Beca use of th e lack of stimul ati on by 
th e sin g le cell suspensions of cultured KC o f all ogeneic PBML 
and the poo r via bilit y and HLA-DH expression after trypsini-
zatio n, we bega n to uti lize K w hi ch w ere g rown and m aintained 
atta ched o n collagen-coated Hat-bottomed mi crotiter wells in the 
presence of rBM L. 
Illilibirillg EJfecr by S illgle Cel l SlIspcllsiollS oj C liitured KC Oil 
ML R: T o understand whether th e lack of stimulati on of allo-
geneic PBML b y sin g le ce ll suspensions of cultured OH + KC 
resu lted fro m [h e presence of an inh ib ito r produ ced by the cul-
tured K C o r from poor v iability and HLA-DR ex press ion during 
the initi al 48 h of incubati on with PBML, we added va ri ous 
co ncentrations of [ry psin ized , cultured KC into a co nvention al 
MLR co ntainin g 5 X 104 res ponde r PBML and 5 X 104 irradi ated 
stimulator all ogeneic PBML. Trypsini zed sin g le cell suspensions 
of cultured KC inhibited [he MLR in a concentra tion-dependent 
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Figure 3. Modulation of induction and disappearance of KC HLA-D H 
expression by PGE~, indomethacin, irrad iation, and removal of r-IFN-
y. O n day 0, the ce lls were treated by ex posing them to r-IFN-y (300 
units/ ml) plus indomethacin (I f.L g/ ml , so lid rrinl/glc;), PGE2 (0. I f.Lg/ ml , 
opel/ circles), irradiation (2000 rads, so lid circles) compared with control , 
untreated cells (solid s1"nrcs) . 011 day 3, the r- IFN-y was removed, thc 
cultures was hcd with complete media, and th e ce lls were stained for HLA-
DR 0 11 days 3-9. 
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Figure 4. Inhibition of MLR by single cell suspensions of trypsinized, 
cultured KC. PBML (5 X 104) from responder A were incubated with 
5 x '104 PMBL from responder B in the presence or absence of the 
indicated numbers of cultured, trypsinized KC. The average [3J-1Jthymidine 
incorporation for the control MLR (without KC) was 21,686 ± 1,259. 
fash ion (Fig 4) . No signifi cant difference in the inhibition was 
seen utilizing either r-IFN-')' pretreated and washed (100-300 
units/ml) or untreated KC or whether we analyzed the MLR on 
day 4 rather than day 7. Preincubating the cultured KC with 
indomethacin (1 ~g/m l) or anti-a, -{3, or -I' interferon antibodies 
(102-103 units/ml neutralizing activity) did not prevent this in-
hibition . 
interaction oj Attached, Cultured KCs, and Allogeneic PBML: When 
KC were seeded at 1-2 x 104 cells/plate and treated with r-IFN-
I' for 3 days to induce HLA-DR expression prior to the addition 
of allogeneic PBML, the r-IFN-,),-treated KC sometimes resulted 
in a slight stimulation (Table I) of PBML [3H]thymidine incor-
poration (range 947-5822 cpm) and this was greater than with 
the untreated KC (range 264--1173 cpm). In 6 experiments (bold-
faced in Table 1), the PBML pH]thymidine incorporation was 
significantly greater (p < 0.05) for the r-IFN-y-treated KC com-
pared with the untreated KC. These 6 experiments have the rel-
ative stimulation ratios (r-IFN-')'-treated vs untreated) provided 
in parentheses. 
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C ultured, attached KC at higher KC seeding densities (5-10 
x 104 cells/ plate) did not stimulate allogeneic PBML either with 
or without r-IFN-y treatment or irradiat ion . No signiflcall t stim-
ulation of PBML was observed whell the attached, cultured KC 
(either with or without r-IFN-y treatment) were preincubated 
with indomethacin (1 ~g/m l), during incubation with allogeneic 
PBML. 
Il1hibitory E.{fect by Attached C"litllred KC 0/1 MLRs: To explore 
the possibility that attached cultured KC produce a product that 
inhibits lymphocyte proliferation, we performed a conventional 
MLR on top of attached, cultured KC. At 5-10 x 104 seeded 
KC/microtiter well a concentration-dependent inhibition of the 
MLR occurred (Fig 5). By contrast when 2 x 104 KC/well were 
preirradiated with 2000 rads before incubation with 2 different 
sets of allogeneic lymphocyte populations, only a 4% inhibition 
of the conventional MLR resulted. This slight inhibition was 
abolished totally when the preirradiated KC cultures were also 
pretreated with indomethacin (1 ~g/111 1) suggesting that irradiated 
KC seeded at low density could no longer produce a factor in 
sufficient quantity to inhibit lymphocyte proliferation. The in-
hibitory effect of the attached, cultured KC at higher seeding 
densities co uld not be reversed by pretreatment with either 2000 
rad, indomethacin, or anti-a, -{3, or -I' interferon antibodies 
(5 X 102-1 04 units /ml neutralizing activity) . To establish whether 
the allogeneic PBML may be killin g the cultured KC, we deter-
mined the number of attached KC per il1icrotiter well before and 
after incubation with allogeneic PBML. The add ition of 5 x 104 
allogeneic PBML did not change the number of viable KC per 
well after 48 h of coincubation (data not shown). Moreover, the 
number and viability of the allogeneic PBML also did not change 
at 48 h and at 6 days of incubation on either r-IFN-,),-treated or 
untreated KC monolayers (data not shown). 
Keratj'10cyte Monolayer-Conditioned RPM! Media Inhibits Lympho-
cyte Proliferation: RPM! media conditioned from 24--96 h on 
attached cultured KC was removed and compared with fresh 
unconditioned nPMI medi\lm for its ability to inhibit lymphocyte 
proliferation (Table II) . The degree of inhibition of the MLR was 
dependent on the length of time the nPMI media had been con-
ditioned on attached cultured KC. The change in pH of the media 
was also monitored and found to be slightly decreased with in-
creasing time of conditioning by the cultured KC. The inhibition 
of lymphocyte proliferation by KC-conditioned media co uld be 
reversed by the addition of fresh complete medium (containing 
Table I. [3H]Thymidine lncorporation by Allogeneic Peripheral Blood Mononuclear Leukocytes (PBMLs) Incubated with 
Attached C ultured Keratinocytes" 
Number of 
Keratinocytes Seeded 
10,000 
20,000 
50,000 
100,000 
Non e 
480 ± 169 
930 ± 493 
264 ± 102 
929 ± 169 
o 
a 
o 
o 
2000 rad 
o 
1173 ± 387 
o 
o 
369 ± 89' 
711 ± 185 
756 ± 231 
769 :': 202' 
o 
595 :': 229 
o 
a 
Treatment 
r-IFN-y" 
1594 ± 128 
4232 ± 593 (2.3) 
1673 ± 293 
5822 ± 628 (2.8) 
1232 ± 618 
1705 ± 805 
o 
480 ± 225 
r-IFN-y + 2000 rad 
947 ± 169 
4680 ± 336 (2.3) 
o 
987 ± 227 
1424 ± 271 
3779 :': 1082 (4.0), 
3963 ± 628 (4.8), 
4331 ± 370 (2.3), 
o 
491 ± 196 
a 
o 
'The [' HJthymidine incorporation represents the mean cpm of triplicate wells on da y 7. Lymphocyte incorporation and kcratinocyte (KC) incorporation alone (backgroundl 
was subtracted. When the [' HJthymidine incorporation by the PBML was statistica ll y signifi cant and increased for HLA-DR + over I-ILA-DR - KC, the ratio is provid~ 
in parentheses. 
' Recombinant IFN--y (300 units/ml) was added [or 3 days, the cells were washed, and then allogeneic PBML were added. A replicate plate o[ KC was harvested at thl 
time o[ I'BMl addition and HLA-Dn expression by the KC was observed. 
'The KC were preincubated with indomethacin (1 /kg/ml) . 
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Figure 5. Inhibition of MLR by attached cultured KC. 
100 
10% human serum) . However, the inhibition was not reversed 
following overni ght dialysis. 
To determine w hether this inhibition could also be observed 
in another sys tem , we examined the effects of conditioned KC 
medium on eH]thymidine incorporation by lectin stimulation of 
PBML. Keratinocyte medium conditioned for 48 h inhibited the 
Con A stimulation ofPBML (p < 0.05). T his inhibition of lym-
phocyte proliferation could not be reversed by preincubating the 
cultured KC (from w hich the conditioned medium was obtained) 
with either indometh acin (1 ,ug/ml) o r anti-a, -{3, o r -y interferon 
antibodies. 
To evaluate the possible role of K C PGE2 production , RPMI 
medium conditioned for 48 h was assayed for PGE2 levels. After 
48 h, cultured human KC produced nano molar levels of PGE2 
(11. 8 nM , T able III) . Pretrea tm ent with irradiation slightl y re-
du ced PGE2 production (9.9 nM), w hereas indomethacin (1 or 10 
,ug/ml) grea tl y reduced the PGE2 level s (2.1 nM). By contrast, 
the addition of r-IFN-y (500 units/ml) increased PGE2 levels ap-
proximately 4.5- fold (54.2 nM). Similar trends were seen in a 
second , separate experiment. 
Changes in PBML Cell Numb er and Cell S ize Fo llowing S timulat ion 
with Con A and/o r DR + and Dl? - Cu ltured KC: Utilizing cul-
Table II. Inhibitory Effect of Conditioned Media From 
Human Keratino cyte Monolayers on Mixed Lymphocyte 
Reactions (MLR) and Con A Stimulated Peripheral Blood 
M ononuclea r Leukocytes (PBML) 
Treat ment 
Control MLR 
MLR in presence of 24-h 
conditioned medium !> 
MLR in presence of 96-h 
conditioned medium 
MLR in presence of 24-h 
conditioned media diluted 
1 : 2 with fresh complete 
medium 
Con A-stimulated PBML" 
Con A-stimulated PBML 
in 48-h conditioned medium 
[3HJThymidine Incorporation" 
pH (cpm) 
7.15 18,392 :±: 1,239 
6.9 12,063 :±: 853' 
6.8 6,906 :±: 775' 
16,847 :±: 1,002 
52,939 ± 1,849 
33,945 ± 1,628' 
'The r3Hlthymid ine inco rporation is the mea n of triplicate wells of 4 experim ents 
in w hich backg round keratinocy te and lymphocyte [3HJth Ylllidine incorporation has 
been subtracted . Responder PBML (5 X 10') were incubated with 5 X 10' irrad iated 
stimulator PBML in RPM I + 10% human serum. 
'There was no reversal o f this in hibition after overnight dialysis. 
'T his inhibito ry response was statistically significant (I' < 0.05). 
' The concentration o f Con A was 50 /Lg/ml. 
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Table III. PGE2 Levels in 48-h Conditioned Keratinocyte 
(KC) M edia 
KCs 
KCs + 2000 rads 
KCs + indomethacin (1 JLg/ml) 
KCs + indomethacin C10 JLg/ ml) 
KCs + r-IFN-y (500 units/ml) 
PGE2 Concentration (nM) 
11.8 
9.9 
2. 1 
2.6 
54.2 
tured endothelial cells and lectin stimulation ofPBML, it has been 
previously suggested that [3H]thymidine incorporation may not 
accurately refl ect lymphocyte proliferation [21,22]. To determine 
whether this discordance could pose a problem in our system we 
analyzed Con A (50 ,ug/ ml)-stimulated PBML on day 7. In keep-
ing w ith previous reports, this lectin stimulation resulted in a 
460% increase in cell number and a 50% increase in cell size. By 
contras t, when PBML were stimulated w ith Con A in the pres-
ence o f 5 X 104 attached KC, only a 15% increase in cell num-
ber/ plate occurred. (Some of this increase could have been du e 
to deta ched KC.) H owever, on day 7, all Con A-treated PBML, 
w hether incubated on KC monolayers or controls, had dramat-
icall y increased in cell size by 48%. This discrepancy between cell 
number and cell size in the experiments using lectin-stimulated 
PBML incubated on KC monolayers suggested that the KC may 
be producing fac tor(s) w hich selectivel y block lymphocyte mi-
togenesis but not activation. 
T o determine w hether HLA-DR + KC w hen incubated with 
allogeneic PBML could cause a similar increase in the cell size, 
we assayed the cell size of PBML after incubation wi th r-IFN-y-
pretreated KC . N o increase in cell size occurred using attached 
KC pretreated w ith 500 uni ts / ml r-IFN-y (results no t shown) . 
A llogeneiC PBML f H] U r'idille Incorporalion Afler Coinwbalion Wilh 
C ultured K C With and Without CO li A: It has been previously 
shown [23] that PGE2 does not affect RNA synthesis of mitogen-
activated lymphocy tes and their entry into G 1, but does affect 
PBML mitogenesis (G1 a-G 1b). Therefore we assessed the effect of 
cultured KC on lymphocyte activa tion and RNA synthesis by 
measurin g [3H]uridine incorpora tion . On day 4, untreated (no r-
IFN-y exposure) cultured KC stimulated incorporation of 
[JH]uridine by PBML approximately 3-fold (Table IV). The same 
stimulation also occurred w hen the cultured KC were pretreated 
with r-IFN-y (500 units/ml) . N o detectable increase in PBML 
cell size or number either on day 4 o r day 7 was seen despite the 
increased [3H]uridine incorporation . 
To add to our observations on the effect of cultured KC on 
[3H]thymidine incorporation by lectin-stimulated PBML, we as-
sayed [3H]urid ine incorporation in the absence and presence of 
cultured KC (Table IV). As expected, the [3H]uridine incorpo-
ration in Con A-stimu lated PBML was markedl y increased over 
the PBML not stimulated w ith Con A. Furtherm ore, cultured 
KC had only a minimal inhibitory effect on [3H]uridine incor-
poration by Con A-stimulated PBML as assessed on day 4. 
St imulation of IFN-y Production by A llogeneic PBML and C ultured 
K C: Since either r-IFN-y-treated or untreated cultured KC 
Table IV. [3H]Uridine Incorporation of Peripheral Blood 
Mononuclea r Leukocytes (PBM L) Incubated w ith 
Keratinocytes and/or Con A 
Treatment [3H]Uridine (cpm) 
PBML alone 
PBML + KC (:±: r-IFN-y) 
PBML + Con A (50 JLg/ml) 
PBML + Con A + KC 
3.950 
11 ,800 
210,650 
185,300 
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stimulate !JBM L to in crease the [3J-l juridine inco rpo ration (Ta ble 
IV) and thus apparen tl y do not block lymphocyte acti va ti on bur 
do inhibit lymph ocyte mitogenesis, we assayed the supern atants 
for IFN-y production by allogeneic PBML coincubated wi th cul-
tured KC. '}' In terferon is known co be prod uced by activated T 
lymphocytes in response to alloantigens 1231. After 5 days o f 
co in cubat ion of all ogcneic PBML with cultured KC , detectable 
leve ls of I ~N-'}' were present in th e conditi oned media (Tab le V). 
PBML alone produced no sign ifica nt leve ls of IFN-y and we 
confirm ed the th o ro ug hn ess of o ur washin g techniques in these 
micro titer wel ls ex posed to r- IFN-y by assay ing the supernatants 
from KC cultured alone. When allogeneic PBML were coincu-
bated with DR + KC th ey produced m ore lFN-y th an with HLA-
DR - KC, but an eq uivalent amo unt of IFN-y (40-200 U / ml) 
W:lS observ ed in subsequ ent ex periments whether either 1-ILA-
DR + o r HLA-DR - KC were used to st imulate th c ·PBML. 
DISCUSS ION 
Prev ious investi ga tors ha ve studied the modu lation of induction 
o f HLA-DR express ion by IFN-y [1 9,24] . We observed that un-
like macrop hagcs in KC, neither the r-IFN-y induction nor dis-
appearance of H LA-DR is influenced by pretrea tm ent with ir-
radiation. PGE2, o r indomethacin. Exposing the cultured KC to 
brief pulses (up to 24 h) of r-1FN-y rather th an continu o us ex-
posure produces a decreased percentage of KC expressing HLA-
DH. 
The interaction of allogeneic PBML w ith cultured KC is com-
plex . To full y interpret the results it is impo rtant to note that T-
cell stimulati on first requi res "acti vation" durin g which cells 
progress frolll Go to G\ and then progression from G I through 
DNA sy nth esis and mitosis (25). Our res ults indi cate that attached 
CLI lturcd KC (either HLA-DR + o r HLA-DR - ) ca n produce rest-
ing T -cell activation sin ce these PBML secreted IFN-'}' and showed 
in creased RN A synthesis. H owever, the allo;mtigeni c signa l(s) by 
the KC did not lead to prominent mitogenes is (r3H]thymidine 
inco rpo ratio n) . While the cultured KC when seeded at low cell 
density, and pretrea ted w ith r- 1FN-y to induce HLA-DR expres-
sion , did produce a small but sta tisti ca ll y signifi cant s tim ulation 
of [3H Jthymid ine incorporation (mJxi rml = 5800 cpm), the bi-
o logic importan ce of rhis result remains unclear. C lea rly, HLA-
DR + , attached cultured KC are not as po tent stimulators of al-
logeneic PDML mitogenesis as mon ocytes or LC [26J but appear 
to be similar to o ther non-bone marrow-deri ved HLA-DR+ cells 
such as endothelial cells 113-16]. 
In a recent repo rt an analogous approach was undertaken usin g 
HLA-DR + cultured fibrobla sts and simi lar results regardin g the 
lack of stimul ation of resting all ogeneic T lymphocytf:s were 
observed 1271. However, w hen [L-2 was added , purified T lym-
phocytes were stimul ated to proliferate after coincubation with 
HLA-DR " fibrobl as ts . These authors co ncluded that HLA-OR + 
fibrobla sts (unlik e macrophages) do not s timulate adequate IL-2 
production by allogeneic T lymphocy tes to sustain lymphocyte 
mitogenesis. 
Table V. y Interferon Productio n by All ogeneic Peripheral 
B lood M ononuclear Leukocytes (PBML) After Coincuba tion 
w ith C ultured Keratinoc yccs 
Cell Mi xture" 
PBML alone 
r-lFN-y trea ted KC alone (afte r 3 washes) 
PB ML + HLA-DR+ KC 
PBML + HLA-Dl1 - KC 
Control MLH. 
y Inter(eron (units/mV' 
0. 1 
1.0 
19.8 
6.7 
65.0 
"PBML (10' ) were co incubatcd wi th 5 X 10' ",mched kcratinocy tcs (KC). The 
HLA-DR+ KC had been pretrea ted wid, 300 lInits/mi r-IFN-y for 3 da ys prior to 
add ition or PDML. 
bThc conditio ned 1I1cdia was removed arter 5 days of Coil1 cubacion w ith PBML 
+ KC and assayed using a radioimmunoassay. 
THE JOUHNAL O F iNVESTIGA TIVE DERMATOLOGY-
Our results indica ting that the presence of HLA-DR. in itself, 
on trypsinized KC is not sufficient to produ ce mi togenesis O~\ 
allogeneic PBML may have seve ral explanations. First, the s in gl~ 
cell suspensions of H LA-DR + cultlln:d KC have a poor viabilit), 
compared with fresh epidermal cells and the HLA-DR + KC m <l)' 
nor be viable in the RPMl m edi.1 for a suffi ciently long period t~ 
stimu late the allogeneic PBML. This exp lanatio n is less like ly fo ~ 
the attached cultured KC as the y maintained a mll ch better via, 
bi li ty alld pro lo nged HLA-DR cxpression after removal ofr-IFN, 
'}' and ex posure to all ogeneic PBM L. Second , the number ofHLA, 
DR molecu les ex pressed per cllltu red KC after r- IFN-y in th ~ 
dose ran ge utilized (100-300 units/m l) may be lower chan LC Cl~ 
monocyte HLA-DR cell surfa ce ex press io ll and inadequate tc\ 
produce o ptimal allogeneic PBML stil11ubtion . Third, additional 
cell surface proteins besides HLA-DR may be impo rtant in aI, 
logeneic PBML reactions and these may not bc inducible by r, 
IFN-y treatment (such as HLA-DQ) in th e KC [9J. Fourth , w~ 
did no t type the specific histocompatibility antigens (class I or II) 
on either ou r stimulator or res ponder cel ls to document differ, 
ences in their respective allel es. H owever, the Jack of stimlllatioI\ 
observed in many ex periments could not be ;Iccounted for by ~ 
chance similarity in histocompatib ility anti gens between the dif, 
ferent stimulato r and responder ce lls. Fifth, the .low level of stirn, 
ul ati on of all ogeneic PBML by cultured HLA-DR + KC m ay bQ 
du e to the presence o f inhibito ry facto rs produccd by the ClIltured, 
KC as has becn previously sugges ted· [4,26]. To in vestigate th~ 
latter alternative we measured PGEz levels and have sho wn then~ 
prcsent in nanomolar amounts in the m ed ium and to be in creased, 
after r- l FN-y exposure. 
Attached cultured KC produced significant am ounts (11.8 nM~ 
of !JGE2. This production W3S slight ly decreased by irrad iat iOl\ 
and markedly decreased with indo methacin pretreatment. Man}\ 
prev ious investigators have observed that nano lll olar co ncen tra\ 
tions of PGE2 inhibit the rJHjth ymidine in corporation by lym\ 
phocy tes after alloantigen reactions o r lectin stimu latio n [28-32] 
With res pect to the mi xed lymphocyte reaction , it has been re~ 
ported that PGE 2 levels present in thc culture supernatants r ang~ 
fro m 10- 8- 10 - 9 M r32j. While 1. 7 nM peEz dccreased the ML~ 
and IJI-I] thymidine incorporatio n by 38%, w ho le macrophag~ 
supern atants that contained identi ca l peE2 levels inhibited th\ 
MLR b y > 70%, suggesting that additiona l factors besid t:s peE, 
may be responsible for inhibitio n of the MLR. [n our system 
the attached cultured KC produ ced a 40-80% inhibition of th ~ 
MLR dependin g on the number of KC seeded. We did no t observ~ 
all Y striking effect o n this inhibition w ith the usc o f indo methacin 
This result sugges ts that PGE2 production, w hile it m ay h av~ 
contributed to so me o f the observed inhibitio n. does not :lCCOUl1\ 
for all of it , and addi ti o nal inhibitory facto rs also may be secreted 
The presc nce of an inhibitory factor(s) (large r than 3500 dalton) 
could also be infef(ed fro lll the dial ys is experim ent in whic~ 
o vernig ht dialysis did not alter the o bserved inhibition. However 
the ro le of PGE2 in our experimenta l sys tem is co mplex, sine~ 
IFN-y (which we added exogeno usly, and which is present ill 
activated PBML supernatants [7]) greatl y increased the KC pro\ 
du ction of peE2 (approxim ate ly 4-fo ld to 54 11M) . Other inves, 
tigators have observed th at human IFN ca n increase the produc, 
tion of PGE2 by noniml11ul1e cells such as cultured fibrob l as~ 
[33,34J . 
DLI[in g Iymphocyte-keratinocy te intera ctions , variable !cvell 
ofPGE~ may be produced , and furthe r stud ies w ith serial ad ditio l\ 
?f mu ltip le inhibitors of PG synthesis (indomethacin plus m eclo" 
tcnamate plus ETY A) WIth redu ction of PGE2 levels below ·l n,,\ 
w ill permit more detailed analysis of additional so luble KC-d~ 
rived inhibitors of PBML m itogenesis . 
Because of the lack of effect of dia lysis and the pretreatmen\ 
with indo m ethacin, as we ll as the increase in [JJ-:I]uridin e incor, 
pora~ion in PBML cultured on KC monolayers, o ur data sugges\ 
the existence of an add it ional KC-derived lympho cyte inhibitot) 
factor (which we have abbreviated KLlF). KUF is proba bly dif\ 
ferent from the epidermal cel l-derived inhibitor reported b) 
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Tsuch id a et al [35 ], as their inhibitor o ra cyto tox ic T-ly mphocy ric 
reaction could be re ve rsed b y prein cuba tin g th e epiderma l ce ll s 
with indometha c in (0. 1- 1.0 j1.g/ ml) and was tenta tivel y identiti ed 
as PGE2. KLiF is probably diffe rent than th e inhibitory fa ctor 
identifi ed by Sa ud er et a l (]J as it is nondialyzable . KLiF ma y be 
s imilar, if not id enti cal, to rh e recentl y d esc ribed "epiderma l ce ll 
derived ly mphocy te differentiari o n facto r" 136J. KLiF pro babl y 
has a s imilar e ffec t on P BML as docs PG E 2 as it d ocs n o t in hibi t 
th e " acti va ti o n " sig nal fo r ly mph ocy te tran s to rmatio n , but d oes 
influen ce [3HJth y midin e in co rpo rati o n b y PBML as well as ly m-
phocy te mitos is. 
Since PGE2 inhi bits I L-2 prod u ction, th e in te ractio n o f PBML 
and K C ma y be influen ced by the additi o n o f exogeno us recom-
binant IL-2 [28.1. It is poss ible that w ith additi o n of IL- 2, the 
all ogeneic res tin g T ly mphocytes wi ll be ab le to progress from 
activation to mi togenes is w hen co in cubated w ith cultured HLA-
DR + KC in a sim il a r fash io n as w ith HLA-DR + fibro blasts [27J. 
Since cu ltured K C s timulate PBML [3HJuridine in corporatio n and 
IFN-y producti o n , it wi ll be interestin g to es tab lish which othe r 
prote ins res u lt durin g thi s pe riod of in creased RNA synthesis . If 
terminal deoxynucleotidy l tran sfe rase [4] is o ne o f th ese proteins, 
then KLIF m ay actuall y be capable of influencing PBML mito-
genes is and di fferenti at io n 125J. 
It is important to furth e r purify the K C -derived inhibitors of 
ly mphocyte prolife rati o n beca use these substances m ay be as im-
portant as lymphocy te s timulating fac tors such as ETAF and 
thymopoeitin in cutaneo us homeostasis. Also, until th ese soluble 
inhibitors ca n be m o dulated o r suppressed, furrher inves ti gatio ns 
into the bio logi c role of K C HLA-DR express io n and ke ratin o-
cy te-I y m phocy te inte rac ti o ns will be ham pe red . 
Our resu lts underscore th e co mplexity of res tin g T-Iy mph ocy te 
ac tivation and prolife ra tio n. PBML appears to recognize K C 31-
loa nti gen and r es po nd with IFN-y secretion suggest in g that thi s 
in vitro s ystem ma y permit further dissectio n of the role of IFN-
'Y in lymphocy te-keratinocyte interac tio ns . 
Note: Since acceptan ce of this m anu sc ript , H ayas hi and Au-
relian have isola ted no np ros taglandin solu ble fac tor(s) d e rived 
from murin e UV B-irradi a ted epiderma l cell s coin cubated with 
HSV-2 antigen whi ch suppresses T -l y mphocy te pro li fe rat io n In 
v itro 0 IITlI1lun o I1 36:1 087- 1092, 1986) . 
Til e al/th ol'S tl/al/k E lM A. PJelldt III ho provided excellcllt ree/llliw i "55ist,lII ce, 
Rl/ei·Chm C hill fOl' pcr/orlllill,Q rll(' PCE, assays , al/{I 0,'. A. C. Allisoll fo r 
reI/ iewill ... 'Z th e mal/Elseripl . 
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